FDA Approves Innovative Novel Drug Delivery System for Treatment of Alzheimer’s Disease

PRESS RELEASE
Published April 20, 2023

Worldwide demand for novel drug delivery systems (NDDS) is predicted to surge at a CAGR of 6.6% from 2022 to 2027. At present, the global novel drug delivery systems market enjoys a valuation of US$ 62.5 billion and is anticipated to climb to a market size of US$ 86 billion by the end of 2027. The Novel Drug Delivery Systems (NDDS) market refers to the development and manufacturing of advanced drug delivery systems that improve the effectiveness and safety of drugs. These systems include various technologies and approaches such as liposomes, microspheres, nanoparticles, transdermal patches, and others

The NDDS market is driven by the increasing demand for targeted and personalized drug delivery, as well as the need to improve patient compliance and convenience. Key technologies in the NDDS market include liposomes, microspheres, nanoparticles, and transdermal patches, among others.

Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7604

The market is segmented by route of administration (oral, injectable, topical, and others), by technology (polymer-based systems, lipid-based systems, and others), and by application (oncology, autoimmune diseases, CNS disorders, and others). North America dominates the global NDDS market, followed by Europe and Asia-Pacific

Key Takeaways from Novel Drug Delivery System Market Study

  • From 2022 to 2027, sales of novel drug delivery systems are slated to rise at 6.6% CAGR.
  • The NDDS market is expected to reach a valuation of US$ 86 billion by 2027.
  • Increasing investments in drug delivery R&D activities, growing demand for drugs in the treatment of chronic illnesses, favorable reimbursement policies, and technological advancements are factors that will positively impact novel drug delivery systems market growth.
  • High costs and stringent regulatory norms are predicted to have an adverse impact on overall NDDS market growth.
  • Oral drug delivery systems are expected to account for a major market share owing to their ease of administration and high availability.
  • Targeted drug delivery systems are expected to witness the fastest growth in demand than other modes of drug delivery over the coming years.

Which Prospects are Shaping Novel Drug Delivery Systems (NDDS) Market Growth Path?

The Novel Drug Delivery Systems (NDDS) market is expected to continue growing due to various prospects shaping its growth path. One major prospect is the increasing demand for personalized medicine and targeted drug delivery. NDDS technologies enable drugs to be delivered to specific sites in the body, improving their efficacy and reducing side effects. Additionally, the rising prevalence of chronic diseases and the need for more effective treatments are driving the growth of the NDDS market. Advancements in technology, such as the development of nanotechnology-based drug delivery systems, are also expected to contribute to market growth. Furthermore, the increasing number of partnerships and collaborations among key players in the market is likely to further propel the growth of the NDDS market in the coming years

Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=7604

Competitive Landscape

Key companies in the novel drug delivery systems market are expected to bolster their focus on the launch of new and modern drug delivery systems equipped with advanced technologies.

  • A brand-new medicine delivery system will be introduced, according to Gulfic Biosciences Ltd., an innovative pharmaceutical business, in June 2022. Gulfic and its French partner created the novel medicine delivery system technology at a reasonable cost. Dual Chamber Bags (DCB) is the name of the new system.
  • A reusable medication delivery device with a wider range of uses will be released in May 2022, according to Jabil Healthcare, a well-known company in the healthcare sector. Due to its reusable nature, the Qfinity Autoinjector Platform will be more affordable than similar products already on the market and is anticipated to further support the sustainability trend in the medication delivery business.

Key players in the Novel Drug Delivery System Market

  • AstraZeneca PLC
  • Boston Scientific
  • Genzyme Co.
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Tolmar
  • GlaxoSmithKline PLC

For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7604

Region-Wise Analysis

North America dominates the global NDDS market due to the presence of well-established healthcare infrastructure, increasing prevalence of chronic diseases, and high healthcare spending. The United States is the largest market in the region due to the increasing demand for targeted drug delivery and rising investments in research and development activities.

Europe is the second-largest market for NDDS, driven by the presence of a large patient pool, increasing demand for personalized medicine, and growing awareness regarding the benefits of NDDS technologies. The United Kingdom, Germany, and France are the major contributors to the growth of the market in the region.

Asia-Pacific is expected to witness significant growth in the NDDS market due to the increasing prevalence of chronic diseases, rising healthcare spending, and growing awareness regarding the benefits of NDDS technologies. Countries such as China, India, and Japan are the major contributors to the growth of the market in the region.

Latin America and the Middle East & Africa are also expected to witness significant growth in the NDDS market due to the increasing prevalence of chronic diseases, rising healthcare expenditure, and increasing demand for targeted drug delivery. However, the market growth in these regions may be hindered by the lack of well-established healthcare infrastructure and limited access to advanced healthcare technologies.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.

Xherald

Xherald is passionate about offering extensive coverage of global business news. Dedicated to creating every participant's notification, it reaches its own reader. Daily our experts offer fresh relevant information regarding what is actually occurring in Markets as well as Business. Our headlines are actually swiftly paced and extensive. Our distributor directory connects you with brand new products or services and its market situation from the most effective companies around the planet. Xherald is driven by its 500+ contributors coming from around the world. Xherald provides local as well as global market intelligence information coverage in sectors ranging from healthcare, IOT, chemicals and 17 more sectors. Our updates are quickly paced and detailed. The news we present is actually a mix of authentic content, community contributions and curated headlines announcements. All of the updates our company supplies must pass a strict criterion of genuineness, relevance and significance to our readers.